Compare · ISPR vs RGC
ISPR vs RGC
Side-by-side comparison of Ispire Technology Inc. (ISPR) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISPR and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.72B, about 32.3x ISPR ($84.4M).
- Over the past year, ISPR is down 53.9% and RGC is down 57.2% - ISPR leads by 3.2 points.
- ISPR has hit the wire 5 times in the past 4 weeks while RGC has been quiet.
- ISPR has more recent analyst coverage (2 ratings vs 0 for RGC).
PerformanceISPR-53.92%RGC-57.17%
2025-09-02+0.00%2026-08-31
- Company
- Ispire Technology Inc.
- Regencell Bioscience Holdings Limited
- Price
- $1.47+5.00%
- $5.50-0.27%
- Market cap
- $84.4M
- $2.72B
- 1M return
- +0.00%
- -10.57%
- 1Y return
- -53.92%
- -57.17%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2021
- News (4w)
- 5
- 0
- Recent ratings
- 2
- 0
Latest ISPR
- Ispire Technology Inc. Appoints Steven Przybyla as President
- Ispire Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Director Cox Brent was granted 53,555 shares, increasing direct ownership by 62% to 139,863 units (SEC Form 4)
- Director Burch Christopher Robert was granted 45,760 shares, increasing direct ownership by 59% to 122,944 units (SEC Form 4)
- Director Fargis John was granted 45,760 shares, increasing direct ownership by 61% to 120,385 units (SEC Form 4)
- BTIG Research initiated coverage on Ispire Technology with a new price target
- SEC Form 8-K filed by Ispire Technology Inc.
- Ispire Technology Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form DEFA14A filed by Ispire Technology Inc.
- SEC Form DEF 14A filed by Ispire Technology Inc.
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited